| J3380 | Injection, vedolizumab, intravenous, 1 mg | 17,400 | $20 | $295.8K |
| J3262 | Injection, tocilizumab, 1 mg | 44,860 | $10 | $224.3K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 8,420 | $30 | $218.9K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 5,280 | $30 | $179.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 540 | $110 | $58.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 470 | $100 | $44.6K |
| Q5121 | Injection, infliximab-axxq, biosimilar, (avsola), 10 mg | 1,310 | $20 | $30.1K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 190 | $120 | $23.1K |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 290 | $20 | $6.7K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 180 | $10 | $2.4K |